Abstract
Objective
The peripheral myelin protein-22 (PMP22) gene is associated with the most common types of inherited neuropathies, including hereditary neuropathy with liability to pressure palsies (HNPP) caused by PMP22 deficiency. However, the function of PMP22 has yet to be defined. Our previous study has shown that PMP22 deficiency causes an impaired propagation of nerve action potentials in the absence of demyelination. In the present study, we tested an alternative mechanism relating to myelin permeability.
Methods
Utilizing Pmp22+/− mice as a model of HNPP, we evaluated myelin junctions and their permeability using morphological, electrophysiological, and biochemical approaches.
Results
We show disruption of multiple types of cell junction complexes in peripheral nerve, resulting in increased permeability of myelin and impaired action potential propagation. We further demonstrate that PMP22 interacts with immunoglobulin domain–containing proteins known to regulate tight/adherens junctions and/or transmembrane adhesions, including junctional adhesion molecule-C (JAM-C) and myelin-associated glycoprotein (MAG). Deletion of Jam-c or Mag in mice recapitulates pathology in HNPP.
Interpretation
Our study reveals a novel mechanism by which PMP22 deficiency affects nerve conduction not through removal of myelin, but through disruption of myelin junctions.
Demyelination denudes axons and shunts depolarizing current out of nerve fibers, leading to either a reduction of conduction velocity or complete failure of action potential propagation. The latter is called conduction block and produces focal sensory/vision loss and limb paralysis. Nodes of Ranvier generate depolarizing currents 5× higher than the minimum required for the induction of an action potential. This excess is called the safety factor, which is greatly diminished once demyelination has occurred.1
Although the loss of myelin is widely regarded as one of the most important mechanisms that alter nerve conduction, effective nerve conduction is also thought to require a proper myelin seal through myelin junctions (such as tight junctions, adherens junctions).2 These junctions seal the spaces between adjacent myelin lamellae as well as spaces between the myelin and axolemma.2 In this study, we investigated this fundamental mechanism by utilizing a rodent model with peripheral myelin protein-22 (Pmp22) deficiency, in which we suspected an abnormality of myelin junctions.
Pmp22 is a tetra-span membrane protein that is primarily expressed in myelinating Schwann cells. A trisomy of human PMP22 causes the most common inherited peripheral nerve disease, Charcot–Marie–Tooth disease type 1A. Solidifying the importance of this gene, heterozygous deletion of PMP22 causes a different disorder, hereditary neuropathy with liability to pressure palsies (HNPP).3 However, the precise biological role of PMP22 is largely unknown.
Patients with HNPP present with focal sensory loss and muscle weakness related to conduction block.4 The hallmark pathology of HNPP is focal myelin thickenings known as tomacula.5 Heterozygous inactivation of the Pmp22 gene in mice (Pmp22+/−) recapitulates the pathologic changes in patients with HNPP.6 However, demyelination in Pmp22+/− mice does not occur until late stages of the disease, but nerve susceptibility to conduction block has been observed as early as 8 weeks of age.6–8 This undermines the previously held assumption that demyelination is the cause of nerve conduction abnormalities in HNPP. In this study, we demonstrate that PMP22 deficiency disrupts the assembly of multiple types of myelin junction protein complexes. These junction abnormalities cause increased myelin permeability, which impairs propagation of action potentials.
Materials and Methods
Mouse and Genotyping
The Pmp22+/− mouse genotyping has been described.6, 8 The institutional animal care and use committee at Vanderbilt University has approved the use of the animals.
K+ Effect on Nerve Conduction
Mice anesthetized by isoflurane were allowed to acclimate to room temperature (22°C). One pair of stimulating electrodes was positioned percutaneously at the paraspinal site where the sciatic nerve forms most proximally. A needle recording electrode was inserted in the lateral gastrocnemius muscle. Recording from this proximal muscle showed negligible variations of compound muscle action potentials (CMAPs) among consecutive stimulations. In contrast, variations in CMAP were larger in the recordings from paw muscles. Minimal variations were a prerequisite for observing the longitudinal effect of potassium. CMAP amplitudes were measured from peak to peak. A segment of sciatic nerve was wrapped in gauze that was soaked with 100mM KCl in Ringer’s buffer or Ringer’s buffer without added KCl. The solutions were refreshed every 3 minutes. For each CMAP, the stimulus intensity was verified as supramaximal. A baseline CMAP prior to the KCl or vehicle was collected. CMAP was then recorded every minute for 30 minutes. All subsequent CMAP amplitudes were normalized by the baseline CMAP to monitor the effect of KCl.
Myelin Permeability to Fluorescent Molecules
Myelin leakage was evaluated using 3 different procedures (see technical details in Fig 1A). The teased nerve fibers were imaged under a fluorescence microscope (Leica [Wetzlar, Germany] DM6000B). Nerve fibers from Pmp22+/+ and Pmp22+/− mice were processed in identical conditions. Fluorescence intensity in the teased nerve fibers was quantified by placing a 5 × 5µm interest box 20µm away from the midline of the node of Ranvier. The image software (Leica AF2.5.0.6735) read the gray values from the interest boxes and calculated the mean density based on the gray values and the areas of the boxes. The final averaged values were derived from 105 Pmp22+/+ fibers and 201 Pmp22+/− fibers.
For teased nerve fiber immunohistochemistry, Western blot, electron microscopy (EM), plasmids, epithelial cell culture, and evaluation of tight junction electrical resistance and coimmuno-precipitation (co-IP),8–10 please see the Supplementary Materials.
Statistics
We compared continuous variables between 2 groups using Student t test. The difference among >2 groups was compared using 1-way analysis of variance if data were under normal distribution or Wilcoxon–Mann–Whitney test if data were not under normal distribution. Descriptive statistics were reported as means±standard deviation. The repeated-measures mixed-effects models were used to compare the mean change in the potassium experiments. Statistical analyses were performed using SAS9.3 and R3.0.0. Two-tailed probability values of <0.05 indicate statistical significance.
Results
Myelin Has Increased Permeability in Pmp22+/− Nerves
To test the permeability of the myelin, sciatic nerves with removal of epineurium were incubated with fluorescent molecules of various sizes (see Fig 1A and Materials and Methods for technical details). After 1 hour, there was a dramatic increase of fluorescein in Pmp22+/− nerve myelin, compared with that in Pmp22+/+ nerve fibers (see Fig 1). This increase was quantitatively confirmed and was present even at the age of 6 weeks, prior to the occurrence of most tomacula between 3 and 6 months.7, 8 The permeability was also increased for large sizes of dextran (70kD).
To exclude effects from hypoxia after nerve dissection, these dyes were locally injected into the sciatic nerves while mice were kept alive for 4 hours (see Fig 1A). Nerves were imaged, and the same difference in myelin permeability was found between the Pmp22+/+ and Pmp22+/− nerves (Supplementary Fig 1).
To determine the axolemmal integrity, distal sciatic nerves were crushed to allow the injected dyes to enter the transected axons and transport for 4 hours (see Fig 1A). Proximal segments 1cm away from the crushed site were examined. The fluorescent dyes were visible in axons but not in myelin (see Fig 1G1–3), suggesting that the axolemma in Pmp22+/− nerve fibers was intact.
The dye penetrance to myelin was not due to endocytosis, an issue that has been well addressed in a previous study.11 Thus, our findings suggest abnormally increased myelin permeability in Pmp22+/−-deficient nerves.
Abnormal Epineurium/Myelin Permeability Alters Nerve Conduction in Pmp22 Deficiency
To test the physiological effect of abnormal permeability, sciatic nerves in live animals were wrapped in gauze soaked with KCl (100mM) solution (Fig 2). Sciatic nerves were stimulated once every minute for a total of 30 minutes. CMAP following each stimulus was recorded at the medial gastrocnemius muscles. Similar approaches have been used to differentiate between intact peripheral nerves and nerves whose junctions are disrupted.12–14 In these studies, pharmacological disruption of peripheral nerve junctions allows ions to penetrate epineurium and reach the periaxonal space to affect axonal potentials. In our studies, due to the tight seal, K+ ions did not affect the wild-type nerve CMAP amplitude. In contrast, the K+ ions significantly decreased the CMAP amplitude in Pmp22+/− nerves. This reduction was recoverable after K+ ions were washed out, indicating that Pmp22+/− perineurium was highly permeable to K+ ions. This is also consistent with the known Pmp22 expression in epineurium.15
Tight Junction Protein Complexes Are Disrupted in Pmp22+/− Nerves
To explain the increased myelin permeability, we evaluated tight junctions by teased nerve fiber immunostaining. Claudin-19, a principal protein of the peripheral nerve myelin tight junction, was identified in the Pmp22+/+ paranodes, outer/inner mesaxons, and weakly in Schmidt–Lanterman incisures (SLIs; omitted in Fig 3). These distributions were fragmented or absent in Pmp22+/− nerves. In addition, claudin-19 was seen to accumulate in the perinuclear region and myelin of Pmp22+/− Schwann cells. Quantification confirmed more abnormalities in tomacula than in nontomaculous regions. These alterations were rarely observed in myelinated nerve fibers of wild type.
Abnormal distribution was also detected for other tight junction proteins, including zonula occludens 1 and 2 (ZO1 and ZO2; Supplementary Fig 2A–D).
Abnormal junction complexes were not a result of broadly altered expression levels of tight junction proteins. All proteins on Western blot showed levels similar to wild-type nerves, with the exception of claudin-5, which was increased in Pmp22+/− nerves compared to Pmp22+/+ nerves (see Supplementary Fig 2E).
To determine whether Pmp22 deficiency affects the electrical resistance of tight junctions, mouse renal medullar epithelial cells were cultured to form a monolayer (see Fig 3). Tight junctions between these cells determine the electrical resistance across the monolayer (see Supplementary Materials for technical details).16 Pmp22 has been localized within the intercellular junctions,15 and thus its deficiency is expected to affect these tight junctions. Electrical resistance in Pmp22+/− junctions was significantly lower than in Pmp22+/+ junctions. Furthermore, the junctions revealed by ZO2 immunostaining were disrupted in Pmp22+/− cultures.
Taken together, these results are consistent with an abnormal localization and function of tight junction complexes in Pmp22-deficient myelin.
Transmembrane Adhesion Proteins Are Mislocalized in Pmp22+/− Nerves
Studies have shown that tomaculalike structures can be recapitulated by deleting any of 4 genes: Jam-c, Mag, Pten, and periaxin.17–20 Reliable periaxin antibodies were not available, Pten and its downstream signaling molecule (Akt) were unchanged in Western blot and immunostaining of Pmp22+/− nerves (Supplementary Fig 3).
Jam-c is a junction protein involved in transmembrane adhesion and regulates tight/adherens junctions. 17, 21, 22 Jam-c was detected in paranodes and SLIs in teased nerve fibers of 5-month-old Pmp22+/+ mice. However, in Pmp22+/− paranodes, Jam-c was either reduced or absent, whereas the staining pattern appeared to be normal in Pmp22+/− SLIs (Fig 4). We quantitatively confirmed the loss of Jam-c in Pmp22+/− paranodes.
In younger Pmp22+/− nerves (3 months old), percentages of Jam-c–positive paranodes/SLIs were normal, including the total level of Jam-c (see Fig 4). Therefore, we compressed the sciatic nerve with a vessel clamp for 30 minutes.8 Injuries have been shown to accelerate the removal of junction proteins in the nerves distal to the injury.23 We reasoned that paranodes/SLIs with a lower abundance of Jam-c should lose their staining quicker than those with normal expression. Moreover, because patients with HNPP are particularly susceptible to paralysis following a nerve compression (hence the “pressure palsy” designation), any junctions that exist in Pmp22+/− nerves may be unstable. Compression induced the disappearance of Jam-c in the Pmp22+/− paranodes/SLIs more severely than in Pmp22+/+ nerves. Similar changes were also observed for Mag staining in 3-month-old Pmp22+/− nerves.
Jam-c has been implicated in the formation of adherens junctions in dermal fibroblasts.24 E-cadherin, a marker of adherens junctions,25 was decreased in naive Pmp22+/− paranodes/SLIs (see Fig 4I). Following nerve compression, E-cadherins were hardly visible. We further examined the adherens junctions under EM as we have described.25 Adherens junctions were significantly decreased in Pmp22+/− nerves compared to Pmp22+/+ nerves (Supplementary Fig 4A–D). Interestingly, a similar change was also noticed in junctions between epineurial cells (see Supplementary Fig 4E, F).
In contrast, the paranodal septate junction proteins, contactin-associated protein (Caspr) and neurofascin, appeared to be similar between Pmp22+/+ and Pmp22+/− mice in both naive and compressed nerves (see Supplementary Fig 4G1–J3).
Taken together, these findings suggest that Pmp22 deficiency alters multiple types of myelin junction complexes.
PMP22 Interacts with Transmembrane Adhesion Proteins
Tomacula develops in the peripheral nerves in the absence of Jam-c or Mag.17, 18 These proteins interact or regulate tight/adherens junction proteins.21, 26 Both Jam-c and Mag were reduced in Pmp22+/− paranodes/SLIs (see Fig 4), leading to speculation that Pmp22 may interact with Jam-c and/or Mag. We performed co-IP by coexpressing human PMP22 and JAM-C or MAG in HEK293 cells. The results demonstrate an interaction between PMP22 and JAM-C and between PMP22 and MAG (Fig 5). This interaction is dependent on the extracellular immunoglobulin (Ig) domain because deletion of the Ig domain of JAM-C, but not the intracellular domain of JAM-C, disrupted this interaction (arrow in Fig 5B). Moreover, the interaction between endogenous Pmp22 and Mag was also detectable in mouse sciatic nerves. However, our experiments showed no interaction between PMP22 and AZGP1 (an Ig domain protein in adipocytes for lipid degradation), or between PMP22 and ZO227 (Supplementary Fig 5).
The interaction between PMP22 and JAM-C/MAG raises an intriguing question. Jam-c and Mag are expressed in noncompact myelin,17, 18 whereas Pmp22 is expressed in compact myelin. This led us to question how they might interact. We speculated that these proteins may overlap during development, but segregate to different domains in mature myelin. We then performed immunostaining. Up to postnatal day 20 (P20), Mag was partially colocalized with Pmp22 in immature internodes, paranodes, and SLIs (arrows in Fig 6A1–E3). By P30, Mag and Pmp22 were confined to their separate compartments (see Fig 6F1, G3). In line with this finding, interactions between endogenous Pmp22 and Mag were detectable by co-IP in mouse sciatic nerves at the age of P9, but not in adult nerves (see Fig 5D).
Together, these findings provide a molecular basis regarding how PMP22 may affect the assembly of junction protein complexes through protein–protein interactions.
Discussion
This study shows that Pmp22 deficiency disrupts and/or destabilizes multiple myelin junction protein complexes and profoundly increases the permeability of myelin. Abnormal permeability of myelin appears to affect the propagation of action potentials, because CMAP amplitude in Pmp22+/− nerves can be reduced by external application of K+ ions. Although myelin is present in Pmp22+/− nerves, this increased permeability of myelin impairs its electrical seal and is functionally comparable to demyelination.
Identification of PMP22 interactions with Ig domain proteins may be pathogenically relevant. First, Jam-c and Mag are either reduced or missing in a portion of Pmp22+/− paranodes/SLIs. Second, ablation of either Jam-c or Mag results in tomacula similar to those in Pmp22+/− nerves.17, 18 Jam-c has been shown to interact directly with ZO1/ZO2.21 Thus, mislocalized Jam-c could contribute to the mislocalization of ZO1/ZO2 in Pmp22+/− nerves, and affects tight/adherens junctions.28 Third, our previous study has demonstrated that Mag−/− nerves, like Pmp22+/− nerves, exhibit susceptibility to conduction block.8 Fourth, the decrease of Ig domain proteins in Pmp22+/− paranodes would affect myelin lamellar adhesion between paranodal loops. This view is supported by literature demonstrating the loosened lamellar adhesion in Pmp22+/− paranodal tomacula.29 Ablation of Jam-c also results in looser adhesion between adjacent paranodal lamellae.17 This may increase the size of pathway-3 (illustrated in Fig 6H, I), which is a recently described pathway affecting myelin permeability.11
At present, it is unclear how Pmp22 deficiency affects the assembly of junction protein complexes through protein–protein interactions during development. However, roughly half the amount of Pmp22 is produced in Pmp22+/− nerves. Some junction complexes are still formed, but unstable. They are dislocated during aging (Jam-c was normal at 3 months, but reduced at 5 months; see Fig 4). This finding is consistent with minor pathology with normal conduction velocity in younger nerves (<8 weeks old).8 However, abnormal myelin permeability is still present in these young nerves (see Fig 1E1–4) and explains their susceptibility to develop conduction block.8
Interestingly, heterozygous knockouts of Jam-c or Mag have normal phenotypes. Only homozygous knockout of the proteins causes tomacula. In addition, ablation of claudin-19 eliminates tight junctions in peripheral nerve myelin, yet this results in minimal abnormalities in nerve conduction.30 These observations are well in line with the finding that PMP22 affects multiple types of myelin junctions, leading to a strong effect on myelin permeability (see diagram in Fig 6H, I).
This mechanism may involve junctions in the epi-/perineurium, because Pmp22, Jam-c, and claudin-5 are all expressed in epi-/perineurial junctions.15, 31 There are morphological changes of junctions between epineurial cells (see Supplementary Fig 4E, F). K+ ions were able to reduce action potential propagation after being externally applied to Pmp22+/− nerves (see Fig 2). Epi-/perineurial junctions, as the initial barrier before K+ accesses the periaxonal spaces,12, 13 would have to become excessively permeable to the ions in Pmp22+/− epi-/perineurium.
Axonal constrictions in the tomacula may impair action potential propagation.8 However, we observed an increase of myelin permeability (see Fig 1 E1–4) and susceptibility to conduction block prior to the onset of tomacula/ axonal constrictions in Pmp22+/− and Mag−/− nerves.8 Therefore, abnormal myelin permeability is sufficient to impair action potential propagation in HNPP, independent of axonal constriction.
In summary, our study provides a novel mechanism that may affect nerve conduction in HNPP. Deficiency of Pmp22 dislocates junction protein complexes (see Fig 6H, I), thereby resulting in excessively permeable myelin, which impairs action potential propagation in the absence of demyelination.
Supplementary Material
Acknowledgment
This research is supported by grants from the NIH National Institute of Neurologic Disorders and Stroke (R01NS066927 to J.L. and R01NS064278 to B.D.C.), and a generous private fund from the Prinzmetal family. Work in our laboratory was also supported by the Swiss National Science Foundation. L.W. is a PhD candidate who has been supported by the China Scholarship Council (2011601075).
We thank Drs C. Sanders, A. Gow, and S. Scherer for their valuable comments on this study; A. Hamilton and J. Zou for their technical assistance; and Drs M. Furuse and P. Brophy for providing claudin-19 and neurofascin antibodies.
Footnotes
Additional Supporting Information may be found in the online version of this article.
Potential Conflicts of Interest
Nothing to report.
References
- 1.Kaji R, Bostock H, Kohara N, et al. Activity-dependent conduction block in multifocal motor neuropathy. Brain. 2000;123(pt 8):1602–1611. doi: 10.1093/brain/123.8.1602. [DOI] [PubMed] [Google Scholar]
- 2.Hartline DK, Colman DR. Rapid conduction and the evolution of giant axons and myelinated fibers. Curr Biol. 2007;17:R29–R35. doi: 10.1016/j.cub.2006.11.042. [DOI] [PubMed] [Google Scholar]
- 3.Li J, Parker B, Martyn C, et al. The PMP22 gene and its related diseases. Mol Neurobiol. 2013;47:673–698. doi: 10.1007/s12035-012-8370-x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Li J, Krajewski K, Lewis RA, et al. Loss-of-function phenotype of hereditary neuropathy with liability to pressure palsies. Muscle Nerve. 2004;29:205–210. doi: 10.1002/mus.10521. [DOI] [PubMed] [Google Scholar]
- 5.Tyson J, Malcolm S, Thomas PK, et al. Deletions of chromosome 17p11.2 in multifocal neuropathies. Ann Neurol. 1996;39:180–186. doi: 10.1002/ana.410390207. [DOI] [PubMed] [Google Scholar]
- 6.Adlkofer K, Martini R, Aguzzi A, et al. Hypermyelination and demyelinating peripheral neuropathy in Pmp22-deficient mice. Nat Genet. 1995;11:274–280. doi: 10.1038/ng1195-274. [DOI] [PubMed] [Google Scholar]
- 7.Adlkofer K, Frei R, Neuberg DH, et al. Heterozygous peripheral myelin protein 22-deficient mice are affected by a progressive demyelinating tomaculous neuropathy. J Neurosci. 1997;17:4662–4671. doi: 10.1523/JNEUROSCI.17-12-04662.1997. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8.Bai Y, Zhang X, Katona I, et al. Conduction block in PMP22 deficiency. J Neurosci. 2010;30:600–608. doi: 10.1523/JNEUROSCI.4264-09.2010. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9.Zhang X, Chow CY, Sahenk Z, et al. Mutation of FIG4 causes a rapidly progressive, asymmetric neuronal degeneration. Brain. 2008;131:1990–2001. doi: 10.1093/brain/awn114. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10.Guo J, Ma YH, Yan Q, et al. Fig4 expression in the rodent nervous system and its potential role in preventing abnormal lysosomal accumulation. J Neuropathol Exp Neurol. 2012;71:28–39. doi: 10.1097/NEN.0b013e31823deda8. [DOI] [PubMed] [Google Scholar]
- 11.Mierzwa A, Shroff S, Rosenbluth J. Permeability of the paranodal junction of myelinated nerve fibers. J Neurosci. 2010;30:15962–15968. doi: 10.1523/JNEUROSCI.4047-10.2010. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12.Todd BA, Inman C, Sedgwick EM, et al. Ionic permeability of the frog sciatic nerve perineurium: parallel studies of potassium and lanthanum penetration using electrophysiological and electron microscopic techniques. J Neurocytol. 2000;29:551–567. doi: 10.1023/a:1011015916768. [DOI] [PubMed] [Google Scholar]
- 13.Todd BA, Inman C, Sedgwick EM, et al. Ionic permeability of the opossum sciatic nerve perineurium, examined using electrophysiological and electron microscopic techniques. Brain Res. 2000;867:223–231. doi: 10.1016/s0006-8993(00)02312-x. [DOI] [PubMed] [Google Scholar]
- 14.Hackel D, Krug SM, Sauer RS, et al. Transient opening of the perineurial barrier for analgesic drug delivery. Proc Natl Acad Sci U S A. 2012;109:E2018–E2027. doi: 10.1073/pnas.1120800109. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15.Notterpek L, Roux KJ, Amici SA, et al. Peripheral myelin protein 22 is a constituent of intercellular junctions in epithelia. Proc Natl Acad Sci U S A. 2001;98:14404–14409. doi: 10.1073/pnas.251548398. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16.Masuda S, Oda Y, Sasaki H, et al. LSR defines cell corners for tricellular tight junction formation in epithelial cells. J Cell Sci. 2011;124:548–555. doi: 10.1242/jcs.072058. [DOI] [PubMed] [Google Scholar]
- 17.Scheiermann C, Meda P, Aurrand-Lions M, et al. Expression and function of junctional adhesion molecule-C in myelinated peripheral nerves. Science. 2007;318:1472–1475. doi: 10.1126/science.1149276. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18.Yin X, Crawford TO, Griffin JW, et al. Myelin-associated glycoprotein is a myelin signal that modulates the caliber of myelinated axons. J Neurosci. 1998;18:1953–1962. doi: 10.1523/JNEUROSCI.18-06-01953.1998. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19.Goebbels S, Oltrogge JH, Wolfer S, et al. Genetic disruption of Pten in a novel mouse model of tomaculous neuropathy. EMBO Mol Med. 2012;4:486–499. doi: 10.1002/emmm.201200227. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20.Gillespie CS, Sherman DL, Fleetwood-Walker SM, et al. Peripheral demyelination and neuropathic pain behavior in periaxin-deficient mice. Neuron. 2000;26:523–531. doi: 10.1016/s0896-6273(00)81184-8. [DOI] [PubMed] [Google Scholar]
- 21.Ebnet K, Schulz CU, Meyer zu Brickwedde MK, et al. Junctional adhesion molecule interacts with the PDZ domain-containing proteins AF-6 and ZO-1. J Biol Chem. 2000;275:27979–27988. doi: 10.1074/jbc.M002363200. [DOI] [PubMed] [Google Scholar]
- 22.Mandicourt G, Iden S, Ebnet K, et al. JAM-C regulates tight junctions and integrin-mediated cell adhesion and migration. J Biol Chem. 2007;282:1830–1837. doi: 10.1074/jbc.M605666200. [DOI] [PubMed] [Google Scholar]
- 23.Jung J, Cai W, Lee HK, et al. Actin polymerization is essential for myelin sheath fragmentation during Wallerian degeneration. J Neurosci. 2011;31:2009–2015. doi: 10.1523/JNEUROSCI.4537-10.2011. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24.Morris AP, Tawil A, Berkova Z, et al. Junctional adhesion molecules (JAMs) are differentially expressed in fibroblasts and colocalize with ZO-1 to adherens-like junctions. Cell Commun Adhes. 2006;13:233–247. doi: 10.1080/15419060600877978. [DOI] [PubMed] [Google Scholar]
- 25.Young P, Boussadia O, Berger P, et al. E-cadherin is required for the correct formation of autotypic adherens junctions of the outer mesaxon but not for the integrity of myelinated fibers of peripheral nerves. Mol Cell Neurosci. 2002;21:341–351. doi: 10.1006/mcne.2002.1177. [DOI] [PubMed] [Google Scholar]
- 26.Ebnet K. Organization of multiprotein complexes at cell-cell junctions. Histochem Cell Biol. 2008;130:1–20. doi: 10.1007/s00418-008-0418-7. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 27.Tisdale MJ. Zinc-alpha2-glycoprotein in cachexia and obesity. Curr Opin Support Palliat Care. 2009;3:288–293. doi: 10.1097/SPC.0b013e328331c897. [DOI] [PubMed] [Google Scholar]
- 28.Hartsock A, Nelson WJ. Adherens and tight junctions: structure, function and connections to the actin cytoskeleton. Biochim Biophys Acta. 2008;1778:660–669. doi: 10.1016/j.bbamem.2007.07.012. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 29.Madrid R, Bradley G. The pathology of neuropathies with focal thickening of the myelin sheath (tomaculous neuropathy): studies on the formation of the abnormal myelin sheath. J Neurol Sci. 1975;25:415–448. [Google Scholar]
- 30.Miyamoto T, Morita K, Takemoto D, et al. Tight junctions in Schwann cells of peripheral myelinated axons: a lesson from claudin-19-deficient mice. J Cell Biol. 2005;169:527–538. doi: 10.1083/jcb.200501154. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 31.Colom B, Poitelon Y, Huang W, et al. Schwann cell-specific JAMC- deficient mice reveal novel expression and functions for JAM-C in peripheral nerves. FASEB J. 2012;26:1064–1076. doi: 10.1096/fj.11-196220. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 32.Balda MS, Whitney JA, Flores C, et al. Functional dissociation of paracellular permeability and transepithelial electrical resistance and disruption of the apical-basolateral intramembrane diffusion barrier by expression of a mutant tight junction membrane protein. J Cell Biol. 1996;134:1031–1049. doi: 10.1083/jcb.134.4.1031. [DOI] [PMC free article] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.